Bacterial, Viral & Fungal Infections Conditions (8)
Respiratory infections, shingles/HSV, pneumonia, skin infections, Lyme disease, HIV, and antimicrobial therapy.
40 Master Condition Specialty Hubs
Show All 40 Hubs ×Bacterial, Viral & Fungal Infections Guides (8)
Clear All Filters ×Zoster conjunctivitis
Zoster conjunctivitis—coded clinically as B02.31 across Infections & Antivirals guidelines—combines rapid antigen/NAAT PCR in Zoster conjunctivitis (B02.31: diagnostics) with structured follow-up of C-Reactive Protein / in Zoster conjunctivitis (B02.31: Procalcitonin) (Resolution to baseline (B02.31)).
Zoster encephalitis
Recognized across U.S. clinical coding as B02.0 (Infections & Antivirals), Zoster encephalitis is evaluated via antimicrobial stewardship (narrow-spectrum in Zoster encephalitis (B02.0: pathogen-directed duration) or) to align day-to-day symptom relief with long-term physiological stability.
Zoster iridocyclitis
Zoster iridocyclitis—coded clinically as B02.32 across Infections & Antivirals guidelines—combines antimicrobial stewardship (narrow-spectrum in Zoster iridocyclitis (B02.32: pathogen-directed duration) or) with structured follow-up of Complete Blood Count in Zoster iridocyclitis (B02.32: (WBC & Differential)) (WBC 4.0 – 10.0 x10^3/uL (B02.32)).
Zoster keratitis
Zoster keratitis is an ICD-10-CM indexed diagnosis (B02.33) within Bacterial, Viral & Fungal Infections. Clinical evaluation centers on antimicrobial stewardship (narrow-spectrum in Zoster keratitis (B02.33: pathogen-directed duration) or) alongside serial C-Reactive Protein / in Zoster keratitis (B02.33: Procalcitonin) tracking (Resolution to baseline (B02.33)) to guide individualized care.
Zoster ocular disease
Recognized across U.S. clinical coding as B02.30 (Infections & Antivirals), Zoster ocular disease is evaluated via antimicrobial stewardship (narrow-spectrum in Zoster ocular disease (B02.30: pathogen-directed duration) or) to align day-to-day symptom relief with long-term physiological stability.
Zoster scleritis
Within Bacterial, Viral & Fungal Infections practice, Zoster scleritis (ICD-10 B02.34) is stratified through sepsis/severity red-flag triage [Zoster scleritis B02.34], pairing targeted symptom control with longitudinal C-Reactive Protein / in Zoster scleritis (B02.34: Procalcitonin) surveillance.
Zoster with other complications
Under Bacterial, Viral & Fungal Infections diagnostic criteria (B02.8), workup for Zoster with other complications integrates sepsis/severity red-flag triage [Zoster with other complications B02.8] with evidence-graded therapy tailored to C-Reactive Protein / in Zoster with other complications (B02.8: Procalcitonin) response.
Zoster without complications
Recognized across U.S. clinical coding as B02.9 (Infections & Antivirals), Zoster without complications is evaluated via rapid antigen/NAAT PCR in Zoster without complications (B02.9: diagnostics) to align day-to-day symptom relief with long-term physiological stability.